WILMINGTON, Del., March 22, 2021 (GLOBE NEWSWIRE) --
Rigrodsky Law, P.A. announces that it is investigating Intec Pharma Ltd. (“Intec”) (NASDAQ GS: NTEC) regarding possible breaches of fiduciary duties and other violations of law related to Intec’s agreement to merge with Decoy Biosystems, Inc.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-intec-pharma-ltd.
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or firstname.lastname@example.org.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.